RO7112689 (crovalimab): Intravenous and Subcutaneous

2 trials

Sponsors

Kanwal John Pasi

Conditions

Atypical Hemolytic Uremic Syndrome

Phase 3

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants with Atypical Hemolytic Uremic Syndrome (aHUS)

Active, not recruitingJPRN-jRCT2031210061

Kanwal John PasiAtypical Hemolytic Uremic Syndrome

Start: 2022-05-10Target: 90Updated: 2026-06-29

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Active, not recruitingJPRN-jRCT2041210086

Kanwal John PasiAtypical Hemolytic Uremic Syndrome

Start: 2022-07-28Target: 45Updated: 2026-06-29